Form 8-K - Current report:
SEC Accession No. 0001104659-22-127798
Filing Date
2022-12-16
Accepted
2022-12-16 16:01:17
Documents
12
Period of Report
2022-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2232896d1_8k.htm   iXBRL 8-K 24326
  Complete submission text file 0001104659-22-127798.txt   198747

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ganx-20221212.xsd EX-101.SCH 3057
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ganx-20221212_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ganx-20221212_pre.xml EX-101.PRE 22611
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2232896d1_8k_htm.xml XML 3708
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 221467870
SIC: 2834 Pharmaceutical Preparations